Yahoo
KSE - Delayed Quote KRW

SK bioscience Co.,Ltd. (302440.KS)

33,500.00 +750.00 (+2.29%)
As of 2:36:09 PM GMT+9. Market Open.
View in AlphaSpace Currency in KRW All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
659,266,711.67
651,368,342.53
267,545,049.15
369,505,555.85
456,725,871.19
Cost of Revenue
564,991,718.95
575,444,142.95
236,569,373.42
227,262,753.95
217,114,929.80
Gross Profit
94,274,992.72
75,924,199.58
30,975,675.73
142,242,801.90
239,610,941.39
Operating Expense
225,528,395
199,425,882
169,406,974
154,230,567
124,597,324
Operating Income
-131,253,402.28
-123,501,682.42
-138,431,298.27
-11,987,765.10
115,013,617.39
Net Non Operating Interest Income Expense
4,837,581.08
6,274,521.97
3,293,170.41
12,157,215.03
2,393,503.80
Pretax Income
-101,178,227.05
-85,860,116.87
-89,106,828.35
7,327,227.38
141,733,182.45
Tax Provision
-15,604,686.27
-29,686,906.68
-38,989,757.89
-14,990,491.85
19,281,232.52
Net Income Common Stockholders
-84,698,537.77
-57,424,481.98
-53,881,198.90
22,317,719.23
122,451,949.93
Basic EPS
-1.08k
-733.00
-698.00
291.00
1.60k
Diluted EPS
-1.08k
-733.00
-698.00
290.00
1.59k
Basic Average Shares
78,377.46
78,341.72
77,193.70
76,693.19
76,724.28
Diluted Average Shares
78,377.46
78,341.72
77,193.70
76,957.65
77,013.81
Total Operating Income as Reported
-131,253,402.63
-123,501,682.76
-138,431,298
-11,987,764.77
115,013,617.84
Rent Expense Supplemental
--
558,263
928,102
153,861
141,753
Total Expenses
790,520,113.95
774,870,024.95
405,976,347.42
381,493,320.95
341,712,253.80
Net Income from Continuing & Discontinued Operation
-84,698,537.77
-57,424,481.98
-53,881,198.90
22,317,719.23
122,451,949.93
Normalized Income
-111,363,135.05
-84,483,174.05
-74,845,773.06
30,609,793.47
116,690,077.88
Interest Income
17,511,321
15,673,740
6,978,080
13,555,354
4,854,444
Interest Expense
12,673,740
9,399,218
3,684,910
1,398,139
2,460,940
Net Interest Income
4,837,581.08
6,274,521.97
3,293,170.41
12,157,215.03
2,393,503.80
EBIT
-88,504,487.05
-76,460,898.87
-85,421,918.35
8,725,366.38
144,194,122.45
EBITDA
9,708,230.95
14,554,714.13
-36,196,684.35
43,490,069.38
171,430,531.45
Reconciled Cost of Revenue
564,991,718.95
575,444,142.95
236,569,373.42
227,262,753.95
217,114,929.80
Reconciled Depreciation
98,212,718
91,015,613
49,225,234
34,764,703
27,236,409
Net Income from Continuing Operation Net Minority Interest
-84,698,537.77
-57,424,481.98
-53,881,198.90
22,317,719.23
122,451,949.93
Total Unusual Items Excluding Goodwill
31,526,996
41,358,905
27,584,966
-10,910,624
6,669,134
Total Unusual Items
31,526,996
41,358,905
27,584,966
-10,910,624
6,669,134
Normalized EBITDA
-21,818,765.05
-26,804,190.87
-63,781,650.35
54,400,693.38
164,761,397.45
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
4,862,398.72
14,300,212.93
6,620,391.84
-2,618,549.76
907,261.95
12/31/2022 - 3/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: